Our Pipeline

  Technology Delivery Feasability Testing Preclinical Phase 1 Phase 2 Phase 3 Launch
Metabolics            
Type 2 Diabetes            
ITCA 650 ›            
Technology Platform Delivery of Exenatide            
Obesity            
ITCA 880 ›            
Technology Platform Delivery of Weight Regulating Endocrine Peptide            
ITCA 884 ›            
Technology Platform Delivery of Weight Regulating Endocrine Peptide            

Intarcia's Technology Platform Feasability Testing

Technology Platform Delivery Feasibility Testing involves development of proprietary formulations and evaluation of drug candidates in those formulations to measure purity, stability and bioactivity of the drug candidate under conditions simulating intended clinical use such as exposure to human body temperature for extended periods of time.